Type 2 Diabetes T2dm clinical trials

Explore recruiting type 2 diabetes t2dm clinical trials.

Recruiting type 2 diabetes t2dm studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Type 2 Diabetes T2dm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes: a double blind RCT

Belgium

Phase III and phase IV (Integrated) EU CTIS Study details

Prospective study to assess with Continuous Glucose Monitoring (CGM) the efficacy and safety of switching to insulin glargine 300 U/ml from insulin glargine 100 U/ml in Type 2 Diabetes (T2DM) patients with renal impairment

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A 52 week prospective randomized controlled study to investigate the effect of intramuscular testosterone undecanoate supplementation vs placebo on intrahepatic fat content in obese men with uncontrolled type 2 diabetes (T2DM) suffering from hypogonadism with a subsequent 108 week open label phase to investigate long term effects on lipid distribution and cardiometabolic parameters in all participating men.

Austria

Therapeutic use (Phase IV) EU CTIS Study details

Type 2 Diabetes T2dm trials by city

Type 2 Diabetes T2dm clinical trials

Recruiting type 2 diabetes t2dm studies right now

Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Endoscopic Sleeve Gastroplasty Plus Duodenal pulsENDO for Obese T2DM

Para-Probiotic Oral Care in Periodontal Patients With Type 2 Diabetes

SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls

A Randomized, Double-blind, Multi-center, Active-controlled, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of THP-00101, THP-00102, and THP-00103 in Subjects With T2DM and Essential Hypertension

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Therapeutic Strategies for Type 2 Diabetes Based on Lifestyle Changes: Plant-based Diet and Physical Exercise

OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)

Ultrasound Effects on Glycemic Control in T2DM

Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

Also recruiting in Europe

Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes: a double blind RCT

Prospective study to assess with Continuous Glucose Monitoring (CGM) the efficacy and safety of switching to insulin glargine 300 U/ml from insulin glargine 100 U/ml in Type 2 Diabetes (T2DM) patients with renal impairment

Type 2 Diabetes T2dm trials by city

Other conditions